Total Funding
75
44
Total FundingGrant raised
Growth Score
-12 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
59621
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
- Marie-Christine Maurel: Founder, Deputy General Manager and CSO
About the Company
Igyxos’ mission is to develop innovative new pharmaceuticals and medical technologies in the field of human fertility. Igyxos is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds such as small molecules and antibodies, and the acquisition of intellectual property rights
to drugs and technologies that can then be brought to the development phase. Igyxos also support the transfer of potential drug candidates to pre-clinical and clinical phases of drug development.
